Oramed Pharmaceuticals Inc. · NASDAQ:ORMP
Oramed Pharmaceuticals Inc. shareholders
As of Jun 30, 2026, 83 institutions reported holding Oramed Pharmaceuticals Inc., 40.3% of its shares. Largest: Mercer Global Advisors Inc, Aquamarine Financial (Cayman) Ltd and Gem Investment Advisors, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Oramed Pharmaceuticals Inc. | Change | Filed |
|---|---|---|---|---|
| Mercer Global Advisors Inc | 3.81M | 9.2% | +1.9M | Aug 19, 2026 |
| Aquamarine Financial (Cayman) Ltd | 2.51M | 6.0% | +400K | Aug 12, 2026 |
| Gem Investment Advisors, LLC | 2M | 4.8% | +359K | Aug 11, 2026 |
| BlackRock | 1.61M | 3.9% | +1.52M | Aug 7, 2026 |
| Murchinson Ltd. | 1.29M | 3.1% | −25,000 | Aug 14, 2026 |
| BML Capital Management, LLC | 866K | 2.1% | −2.3M | Aug 7, 2026 |
| Boothbay Fund Management, LLC | 579K | 1.4% | −22,078 | Aug 14, 2026 |
| Geode Capital | 501K | 1.2% | +476K | Aug 12, 2026 |
| Goldman Sachs | 253K | 0.61% | new | Aug 14, 2026 |
| Vanguard | 244K | 0.59% | new | Aug 13, 2026 |